CA
BIIB icon

Cullinan Associates’s Biogen BIIB Stock Holding History

Cullinan Associates’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,100
Closed -$285K – 242
2023
Q4 		$285K Hold
1,100
– – 0.02% 212
2023
Q3 		$283K Hold
1,100
– – 0.02% 222
2023
Q2 		$313K Hold
1,100
– – 0.02% 220
2023
Q1 		$306K Hold
1,100
– – 0.02% 219
2022
Q4 		$305K Hold
1,100
– – 0.02% 245
2022
Q3 		$294K Hold
1,100
– – 0.02% 206
2022
Q2 		$224K Hold
1,100
– – 0.01% 216
2022
Q1 		$232K Hold
1,100
– – 0.01% 225
2021
Q4 		$264K Sell
1,100
-2,654
-71% -$637K 0.01% 215
2021
Q3 		$1.06M Buy
3,754
+120
+3% +$33.9K 0.06% 143
2021
Q2 		$1.26M Sell
3,634
-12,000
-77% -$4.15M 0.07% 133
2021
Q1 		$4.37M Buy
15,634
+7,420
+90% +$2.08M 0.25% 96
2020
Q4 		$2.01M Sell
8,214
-13,074
-61% -$3.2M 0.12% 112
2020
Q3 		$6.04M Sell
21,288
-1,389
-6% -$394K 0.39% 69
2020
Q2 		$6.07M Buy
22,677
+6,578
+41% +$1.76M 0.43% 64
2020
Q1 		$5.09M Buy
16,099
+20
+0.1% +$6.33K 0.42% 64
2019
Q4 		$4.77M Sell
16,079
-281
-2% -$83.4K 0.32% 84
2019
Q3 		$3.81M Buy
16,360
+1,297
+9% +$302K 0.27% 88
2019
Q2 		$3.52M Sell
15,063
-6,257
-29% -$1.46M 0.26% 94
2019
Q1 		$5.04M Buy
21,320
+3,673
+21% +$868K 0.38% 73
2018
Q4 		$5.31M Buy
17,647
+5,820
+49% +$1.75M 0.44% 57
2018
Q3 		$4.18M Buy
11,827
+1,479
+14% +$523K 0.3% 89
2018
Q2 		$3M Buy
+10,348
New +$3M 0.23% 99
2018
Q1 		– Sell
-650
Closed -$207K – 185
2017
Q4 		$207K Hold
650
– – 0.02% 182
2017
Q3 		$204K Buy
+650
New +$204K 0.02% 189